1-[2-[4-[(5-bromo-4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol;1-bromopyrrolidine-2,5-dione;1-[2-[4-[(4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol

C40H45Br2F2N9O4 — CID 165075315

IUPAC1-[2-[4-[(5-bromo-4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol;1-bromopyrrolidine-2,5-dione;1-[2-[4-[(4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol
SMILESCCc1cn(Cc2cn(C)nc2-c2ccc(F)cc2C(C)O)cn1.CCc1ncn(Cc2cn(C)nc2-c2ccc(F)cc2C(C)O)c1Br.O=C1CCC(=O)N1Br
InChIInChI=1S/C18H20BrFN4O.C18H21FN4O.C4H4BrNO2/c1-4-16-18(19)24(10-21-16)9-12-8-23(3)22-17(12)14-6-5-13(20)7-15(14)11(2)25;1-4-15-10-23(11-20-15)9-13-8-22(3)21-18(13)16-6-5-14(19)7-17(16)12(2)24;5-6-3(7)1-2-4(6)8/h5-8,10-11,25H,4,9H2,1-3H3;5-8,10-12,24H,4,9H2,1-3H3;1-2H2
InChIKeyUFDKOZMOYOVMGF-UHFFFAOYSA-N
MW913.66 g/mol
LogP7.38
Rot. Bonds10

About 1-[2-[4-[(5-bromo-4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol;1-bromopyrrolidine-2,5-dione;1-[2-[4-[(4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol

1-[2-[4-[(5-bromo-4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol;1-bromopyrrolidine-2,5-dione;1-[2-[4-[(4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol (PubChem CID 165075315) has the molecular formula C40H45Br2F2N9O4 and a molecular weight of 913.66 g/mol. Its IUPAC name is 1-[2-[4-[(5-bromo-4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol;1-bromopyrrolidine-2,5-dione;1-[2-[4-[(4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol.

Molecular Properties

Compound Name1-[2-[4-[(5-bromo-4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol;1-bromopyrrolidine-2,5-dione;1-[2-[4-[(4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol
PubChem CID165075315
Molecular FormulaC40H45Br2F2N9O4
Molecular Weight913.66 g/mol
Exact Mass911.19
IUPAC Name1-[2-[4-[(5-bromo-4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol;1-bromopyrrolidine-2,5-dione;1-[2-[4-[(4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol
SMILESCCc1cn(Cc2cn(C)nc2-c2ccc(F)cc2C(C)O)cn1.CCc1ncn(Cc2cn(C)nc2-c2ccc(F)cc2C(C)O)c1Br.O=C1CCC(=O)N1Br
InChIInChI=1S/C18H20BrFN4O.C18H21FN4O.C4H4BrNO2/c1-4-16-18(19)24(10-21-16)9-12-8-23(3)22-17(12)14-6-5-13(20)7-15(14)11(2)25;1-4-15-10-23(11-20-15)9-13-8-22(3)21-18(13)16-6-5-14(19)7-17(16)12(2)24;5-6-3(7)1-2-4(6)8/h5-8,10-11,25H,4,9H2,1-3H3;5-8,10-12,24H,4,9H2,1-3H3;1-2H2
InChIKeyUFDKOZMOYOVMGF-UHFFFAOYSA-N
XLogP7.38
TPSA149.12 Ų
H-Bond Donors2
H-Bond Acceptors12
Rotatable Bonds10
Heavy Atoms57
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500913.66
LogP ≤ 57.38
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'N-halo', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 1-[2-[4-[(5-bromo-4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol;1-bromopyrrolidine-2,5-dione;1-[2-[4-[(4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[2-[4-[(5-bromo-4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol;1-bromopyrrolidine-2,5-dione;1-[2-[4-[(4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol?
The IUPAC name of 1-[2-[4-[(5-bromo-4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol;1-bromopyrrolidine-2,5-dione;1-[2-[4-[(4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol (CID 165075315) is 1-[2-[4-[(5-bromo-4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol;1-bromopyrrolidine-2,5-dione;1-[2-[4-[(4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol.
What is the SMILES notation for 1-[2-[4-[(5-bromo-4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol;1-bromopyrrolidine-2,5-dione;1-[2-[4-[(4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol?
The canonical SMILES for 1-[2-[4-[(5-bromo-4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol;1-bromopyrrolidine-2,5-dione;1-[2-[4-[(4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol is CCc1cn(Cc2cn(C)nc2-c2ccc(F)cc2C(C)O)cn1.CCc1ncn(Cc2cn(C)nc2-c2ccc(F)cc2C(C)O)c1Br.O=C1CCC(=O)N1Br.
What is the InChIKey of 1-[2-[4-[(5-bromo-4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol;1-bromopyrrolidine-2,5-dione;1-[2-[4-[(4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol?
The InChIKey is UFDKOZMOYOVMGF-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H20BrFN4O.C18H21FN4O.C4H4BrNO2/c1-4-16-18(19)24(10-21-16)9-12-8-23(3)22-17(12)14-6-5-13(20)7-15(14)11(2)25;1-4-15-10-23(11-20-15)9-13-8-22(3)21-18(13)16-6-5-14(19)7-17(16)12(2)24;5-6-3(7)1-2-4(6)8/h5-8,10-11,25H,4,9H2,1-3H3;5-8,10-12,24H,4,9H2,1-3H3;1-2H2.
What are the key properties of 1-[2-[4-[(5-bromo-4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol;1-bromopyrrolidine-2,5-dione;1-[2-[4-[(4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol?
1-[2-[4-[(5-bromo-4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol;1-bromopyrrolidine-2,5-dione;1-[2-[4-[(4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol has a molecular weight of 913.66 g/mol, XLogP of 7.38, 10 rotatable bonds, 2 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[2-[4-[(5-bromo-4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol;1-bromopyrrolidine-2,5-dione;1-[2-[4-[(4-ethylimidazol-1-yl)methyl]-1-methylpyrazol-3-yl]-5-fluorophenyl]ethanol is sourced from PubChem (CID 165075315), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).